Nwam LLC raised its holdings in shares of ARK Genomic Revolution ETF (BATS:ARKG – Free Report) by 55.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,704 shares of the company’s stock after buying an additional 11,294 shares during the period. Nwam LLC owned about 0.07% of ARK Genomic Revolution ETF worth $1,333,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently modified their holdings of ARKG. Ascentis Independent Advisors purchased a new stake in shares of ARK Genomic Revolution ETF in the first quarter worth approximately $26,000. PNC Financial Services Group Inc. boosted its holdings in ARK Genomic Revolution ETF by 53.2% during the 1st quarter. PNC Financial Services Group Inc. now owns 1,088 shares of the company’s stock valued at $29,000 after acquiring an additional 378 shares during the period. Sunbelt Securities Inc. boosted its holdings in ARK Genomic Revolution ETF by 734.3% during the 3rd quarter. Sunbelt Securities Inc. now owns 1,118 shares of the company’s stock valued at $31,000 after acquiring an additional 984 shares during the period. Western Wealth Management LLC bought a new position in ARK Genomic Revolution ETF in the 1st quarter valued at $37,000. Finally, Strategic Wealth Investment Group LLC bought a new position in ARK Genomic Revolution ETF in the 2nd quarter valued at $38,000.
ARK Genomic Revolution ETF Trading Up 0.7%
ARKG stock opened at $47.15 on Thursday. The business’s fifty day simple moving average is $42.77 and its two-hundred day simple moving average is $34.52. ARK Genomic Revolution ETF has a twelve month low of $24.20 and a twelve month high of $50.53.
About ARK Genomic Revolution ETF
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
Featured Stories
- Five stocks we like better than ARK Genomic Revolution ETF
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
